DESIGNS FOR HEALTH OEA 30G

DESIGNS FOR HEALTH OEA 30G

Oleoylethanolamide for extemporaneous compounding only

Australia-first supply of Trpti OEA™, a next-generation oleoylethanolamide (OEA).

OEA is an endogenous fatty acid amide, synthesised in the small intestine, and classified as a bioactive mono-unsaturated lipid mediator within the acylglycerol
and N-acylethanolamine families.

LipiSperse® delivery technology to address the bioavailability limitations of standard OEA.

Dosage:
For extemporaneous compounding only

Warnings:
For extemporaneous compounding only. This product must be dispensed by a qualified health professional.
If you become aware of use outside these conditions, please notify Designs for Health Australia using the contact details provided.